Me-4(18F)DG
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Me-4(18F)DG
- DrugBank Accession Number
- DB19207
- Background
Me-4(18F)DG is under investigation in clinical trial NCT05558904 (An Investigational Scan (Me-4fdg PET/CT) for the Detection of Sodium-glucose Transport for Early Diagnosis of Lung Cancer).
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 195.177
Monoisotopic: 195.077236186 - Chemical Formula
- C7H13FO5
- Synonyms
- .alpha.-d-glucopyranoside, methyl 4-deoxy-4-(fluoro-18f)-
- .alpha.-methyl-4-(F-18)-fluoro-4-deoxy-d-glucopyranoside
- (2s,3r,4r,5s,6r)-5-(fluoro-18f)-6-(hydroxymethyl)-2-methoxytetrahydro-2h-pyran-3,4-diol
- Alpha-methyl-4-deoxy-4-((18)f)fluoro-d-glucopyranoside
- External IDs
- Me-4(18F)DG
- Me-4FDG
- Me4FDG
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 5INH2Q4NR1
- CAS number
- 915776-36-2
- InChI Key
- PGYKOSXDWWGTOB-XZWCPNKHSA-N
- InChI
- InChI=1S/C7H13FO5/c1-12-7-6(11)5(10)4(8)3(2-9)13-7/h3-7,9-11H,2H2,1H3/t3-,4-,5+,6+,7+/m1/s1/i8-1
- IUPAC Name
- SMILES
- CO[C@H]1O[C@H](CO)[C@@H]([18F])[C@H](O)[C@H]1O
References
- General References
- Not Available
- External Links
- ChemSpider
- 81367722
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data1, 2 Recruiting Diagnostic Adenocarcinoma of the Lung 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at July 08, 2024 22:02 / Updated at July 10, 2024 02:16